GammaMetric monitors deployed radiology AI in real time and alerts when acquisition drift is degrading model performance. Physics-grounded sensitivity prediction from DICOM metadata — not statistical anomaly detection.
Three studies run through the sensitivity engine. Each shows raw input, raw output, and what it means clinically.
Real-time AI reliability monitoring is live. CT dose analytics runs alongside it — the same physics infrastructure, two clinical problems solved.
Two analyses showing exactly what GammaMetric measures — and what it finds.
Dose compliance. Image quality. AI performance. Most CT protocol reviews address one. This analysis shows how the parameters interact — and which ones actually matter.
Post-deployment validation of a CT lung nodule detection algorithm across six real-world imaging perturbations. Based on LIDC-IDRI (154 cases). Methodology: arXiv:2603.26785.
Most imaging providers and research organizations are flying blind. Dose settings drift. Protocols go unreviewed. AI tools get deployed without validation against real acquisition conditions. The gap is invisible until something goes wrong.
Dose settings from years ago are still running on most outpatient CT scanners. Nobody decided to keep them — nobody decided to change them either. The result is unnecessary dose, inconsistent image quality, and benchmarks that quietly drift out of range.
Passing Leapfrog Section 8B means your numbers are below the threshold — not that your protocols are optimized. Most facilities stop at compliance. The gap between "acceptable" and "excellent" is where dose reduction opportunities live.
FDA-cleared imaging AI is tested at controlled dose levels and standard protocols. Your facility runs lower doses, thicker slices, and varied techniques. Nobody tested what happens in that gap — until now.
Once configured, GammaMetric runs continuously in the background. Every study that passes through your scanner is classified automatically — no uploads, no manual review, no intervention required.
Configure your scanner to forward studies to a lightweight Orthanc DICOM listener. Only acquisition metadata is extracted — no pixel data, no image storage, no PHI transmitted.
Each study runs through the sensitivity engine. Slice thickness, reconstruction kernel, and dose level are mapped to an estimated sensitivity value. The study is classified GREEN, YELLOW, or RED.
RED studies trigger an immediate email to your AI governance contact. YELLOW studies appear in a daily digest. Every study is logged with its classification, parameters, and sensitivity estimate.
Generate a 7-page site-specific reliability report from any study — acquisition profile, sensitivity degradation analysis, and prioritized protocol recommendations. Suitable for post-market surveillance documentation.
Request a Demo →Self-serve CT dose monitoring at dose.gammametric.com. Leapfrog Section 8B reporting, ACR DIR benchmarking, drift alerts. Free to use.
Try It Free →Median DLP for routine head and abdomen-pelvis CT across all five Leapfrog pediatric age groups (<1, 1–4, 5–9, 10–14, 15–17) — formatted and ready for Section 8B reference.
Your facility's dose percentiles compared against ACR Dose Index Registry national reference levels. Clear status flags — Excellent, Acceptable, or Above Benchmark — for every body region.
Automatic identification of exams with unusually high DLP — repeat acquisitions, wrong protocols, or multi-phase studies — with transparent methodology notes for your physics team.
Physicist observations on protocol consistency, scanner variability, and dose reduction opportunities — useful context for your quality improvement program beyond compliance reporting.
Dose trends visualized across your full reporting period. Identify protocol changes, scanner drift, or technologist variability — supporting ongoing QA program development beyond Leapfrog season.
Publication-quality output with percentile tables, benchmark charts, methodology documentation, and your facility name — suitable for quality committee presentation or Leapfrog submission reference.
GammaMetric's own pilot study quantifies how acquisition variability affects imaging AI — and why protocol optimization matters beyond compliance.
Sensitivity drop in CT lung nodule detection AI at 25% dose reduction — a protocol choice many facilities make routinely, with unquantified impact.
Sensitivity drop at 5mm slice thickness versus standard. The gap between your protocol and the vendor's validation conditions is rarely measured.
GammaMetric turnaround from data submission to physicist-reviewed dose analytics or protocol optimization report.
AI monitoring is the primary product. CT dose analytics runs alongside it, free.
15-minute demo. Live system, real DICOM parameters, real alert. No slides.
Or email directly: daniel@gammametric.com